ProjectBRAINIP
Basic data
Title:
BRAINIP
Duration:
01/11/2016 to 31/10/2019
Abstract / short description:
CA209-429 - An Open Label Phase 11 Study to Evaluate Safety and Efficacy of Combined Treatment with Ipilimumab and Nivolumab in Patients with Up to Five Brain Metastases
of Melanoma - BRAINIP-Trial
of Melanoma - BRAINIP-Trial
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Tampouri, Ioanna
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Wilhelmi-Dick, Julia-Alexandra
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Thomas, Ioannis
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Lomberg, Diana
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Spänkuch, Iris
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
München, Bayern, Germany